BMRN vs PRPO · P/E 40, rev $1.76B vs rev $13.7M
Biomarin Pharmaceutical Inc (BMRN) versus Precipio Inc (PRPO) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Precipio Inc (PRPO) is a diagnostics & research company listed on NASDAQ.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported PRPO revenue for 2026-06-30 was $13.7M. Net income was -$1.7M. PRPO currently screens at market cap $39.0M.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. PRPO currently screens at market cap $39.0M.
Not investment advice. Open the BMRN and PRPO stock pages for the full models.
Not investment advice.